- Home
- NKTX vs PLL Comparison
NKTX vs PLL Comparison
Compare NKTX & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- PLL
- Stock Information
- Founded
- NKTX 2015
- PLL 2016
- Country
- NKTX United States
- PLL United States
- Employees
- NKTX N/A
- PLL N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- PLL Other Metals and Minerals
- Sector
- NKTX Health Care
- PLL Basic Materials
- Exchange
- NKTX Nasdaq
- PLL Nasdaq
- Market Cap
- NKTX 225.1M
- PLL 238.0M
- IPO Year
- NKTX 2020
- PLL 2017
- Fundamental
- Price
- NKTX $2.45
- PLL $13.28
- Analyst Decision
- NKTX Strong Buy
- PLL Buy
- Analyst Count
- NKTX 5
- PLL 9
- Target Price
- NKTX $17.00
- PLL $21.33
- AVG Volume (30 Days)
- NKTX 1.2M
- PLL 898.6K
- Earning Date
- NKTX 11-07-2024
- PLL 11-12-2024
- Dividend Yield
- NKTX N/A
- PLL N/A
- EPS Growth
- NKTX N/A
- PLL N/A
- EPS
- NKTX N/A
- PLL N/A
- Revenue
- NKTX N/A
- PLL $46,981,000.00
- Revenue This Year
- NKTX N/A
- PLL $155.85
- Revenue Next Year
- NKTX N/A
- PLL $13.29
- P/E Ratio
- NKTX N/A
- PLL N/A
- Revenue Growth
- NKTX N/A
- PLL N/A
- 52 Week Low
- NKTX $2.38
- PLL $6.57
- 52 Week High
- NKTX $16.24
- PLL $31.82
- Technical
- Relative Strength Index (RSI)
- NKTX 26.80
- PLL 55.62
- Support Level
- NKTX $2.40
- PLL $9.77
- Resistance Level
- NKTX $3.81
- PLL $13.25
- Average True Range (ATR)
- NKTX 0.25
- PLL 1.31
- MACD
- NKTX -0.02
- PLL -0.10
- Stochastic Oscillator
- NKTX 4.90
- PLL 72.69
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About PLL Piedmont Lithium Inc.
Piedmont Lithium Inc, is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and world-wide energy security. Its portfolio of wholly-owned projects includes Carolina Lithium, a proposed fully integrated spodumene ore-to-lithium hydroxide project in Gaston County, North Carolina, and Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee.